Early expression of thyroid hormone deiodinases and receptors in human fetal cerebral cortex

Developmental Brain Research

Volumn 138, Issue 2, 2002, Pages 109-116

  Chan, Shiao ^a   Kachilele, Stivelia ^a   McCabe, Chris J ^a   Tannahill, Lesley A ^a   Boelaert, Kristien ^a   Gittoes, Neil J ^a   Visser, Theo J ^b   Franklyn, Jayne A ^a   Kilby, Mark D ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cortex; Fetus; Thyroid hormone

Indexed keywords

ENZYME; ISOENZYME; MESSENGER RNA; RECEPTOR SUBTYPE; THYROID HORMONE DEIODINASE; THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FETUS; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SECOND TRIMESTER PREGNANCY;

ADULT; CEREBRAL CORTEX; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GESTATIONAL AGE; HUMANS; IODIDE PEROXIDASE; PREGNANCY; RECEPTORS, THYROID HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA-DIRECTED DNA POLYMERASE;

EID: 0037145436     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(02)00459-5     Document Type: Article

References (42)

1. Asteria C. Crutial role for type 2 iodothyronine deiodinase in metabolic coupling between glial cells and neurons during brain development. Eur. J. Endocrinol. 138:1998;370-371.
2. Berry M.J., Kieffer J.D., Harney J.W., Larsen P.R. Selenocysteine confers the biochemical properties characteristic of the type I iodothyronine deiodinase. J. Biol. Chem. 266:(22):1991;14155-14158.
3. Calvo R., Oberon M.J., Ruiz de Ona C., Escbar de rey F., Morreale de Escobar G. Congenital hypothyroidism: as studied in rats. J. Clin. Invest. 86:1990;889-899.
4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:(1):1987;156-159.
5. Contempre B., Jauniaux E., Calvo R., Jurkovic D., Campbell S., de Escobar G.M. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J. Clin. Endocrinol. Metab. 77:(6):1993;1719-1722.
6. Croteau W., Davey J.C., Galton V.A., St. Germain D.L. Cloning of the mammalian type II iodothyronine deiodinase: a selenoprotein differentially expressed and regulated in human and rat brain and other human tissues. J. Clin. Invest. 98:1996;405-417.
7. Fisher D.A., Dussault J.H., Foley T.P. Jr., Klein A.H., LaFranchi S., Larsen P.R., Mitchell M.L., Murphy W.H., Walfish P.G. Screening for congenital hypothyroidism: results of screening one million North American infants. J. Pediatr. 94:(5):1979;700-705.
8. Guadano-Ferraz A., Obergon M.J., St. Germain D.L., Bernal J. The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc. Natl. Acad. Sci. USA. 94:(10):1997;391-396.
9. Haddow J.E., Palomaski G.E., Allan W.C., Williams J.R., Knight G.J., Gagnon J., et al. Maternal and thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New Engl. J. Med. 314:1999;549-555.
10. Hern W.M. Correlation of fetal age and measurements between 10 and 26 weeks of gestation. Obstet. Gynecol. 63:(1):1984;26-32.
11. Heyerdahl S., Kase B.F., Lie S.O. Intellectual development in children with congenital hypothyroidism in relation to recommended thyroxine treatment. J. Pediatr. 118:(6):1991;850-857.
12. Hodin R.A., Lazar M.A., Chin W.W. Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone. J. Clin. Invest. 85:(1):1990;101-105.
13. Iskaros J., Pickard M., Evans I., Sinha A., Hardiman P., Ekins R R. Thyroid hormone gene expression in first trimester human fetal brain. J. Clin. Endocrinol. Metab. 85:2000;2620-2623.
14. Kaplan M.M., Yaskoski K.A. Maturational patterns of iodothyronine phenolic and tyrosyl ring deiodinase activities in rat cerebrum, cerebellum, and hypothalamus. J. Clin. Invest. 67:(4):1981;1208-1214.
15. Kilby M.D., Gittoes N., Verhaeg J., McCabe C., Franklyn J.A. Expression of thyroid receptor isoforms in the human fetal central nervous system and the effects of intrauterine growth restriction. Clin. Endocrinol. 13:2000;469-477.
16. Kilby M.D., Verhaeg J., Gittoes N., Somerset D.A., Clark P.M., Franklyn J.A. Circulating thyroid hormone concentrations and placental thyroid hormone receptor expression in normal human pregnancy and pregnancy complicated by intrauterine growth restriction (IUGR). J. Clin. Endocrinol. Metab. 83:(8):1998;2964-2971.
17. Kohrle J. Local activation and inactivation of thyroid hormones: the deiodinase family. Mol. Cell. Endocrinol. 151:(1-2):1999;103-119.
18. Kohrle J. The deiodinase family: selenoenzymes regulating thyroid hormone availability and action. Cell. Mol. Life Sci. 57:(13-14):2000;1853-1863.
19. Koopdonk-Kool J.M., de Vijlder J.J., Veenboer G.J., Ris-Stalpers C., Kok J.H., Vulsma T., Boer K., Visser T.J. Type II and type III deiodinase activity in human placenta as a function of gestational age. J. Clin. Endocrinol. Metab. 81:(6):1996;2154-2158.
20. H. Lagercrantz, T. Ringstedt, Epigenetic and functional organization of neuronal circuits in the CNS during development, in: M. Levene, F.A. Chervenak, M.J. Whittle (Eds.) Fetal and Neonatal Neurology & Neorosurgury, 3rd Edition, Churchill Livingstone, UK, 1988, pp. 3-10.
21. Lane J.T., Godbole M., Strait K.A., Schwartz H.L., Oppenheimer J.H. Prolonged fasting reduces rat hepatic beta 1 thyroid hormone receptor protein without changing the level of its messenger ribonucleic acid. Endocrinology. 129:(6):1991;2881-2885.
22. Larsen P.R., Silva J.E., Kaplan M.M. Relationships between circulating and intracellular thyroid hormones: physiology and clinical implications. Endocrine Rev. 2:1981;87-102.
23. Lazar M. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocrine Rev. 14:1993;184-193.
24. Legrand J. Thyroid hormones and maturation of the nervous system. Journal de Physiologie. 78:(7):1982;603-652.
25. Mandel S.J., Berry M.J., Kieffer J.D., Harney J.W., Warne R.L., Larsen P.R. Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinase. J. Clin. Endocrinol. Metab. 75:(4):1992;1133-1139.
26. D. Marinkovic, M.H.A. Kester, E. Kaptein, E. Fliers, R. Hume, T.J. Visser, Thyroid hormone metabolism in human fetal brain, Thyroid. Abstract for the Am.Thyroid Ass. 2001.
27. McTernan C.L., Draper N., Nicholson H., Chalder S.M., Driver P., Hewison M., Kilby M.D., Stewart P.M. Reduced placental 11β-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: An analysis of possible mechanisms. J. Clin. Endocrinol. Metab. 86:2001;4979-4983.
28. Mol J.A., Visser T.J. Synthesis and some properties of sulfate esters and sulfamates of iodothyronines. Endocrinology. 117:(1):1985;1-7.
29. Morreale de Escobar G., Obregon M.J., Escobar del Rey F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J. Clin. Endocrinol. Metab. 85:(11):2000;3975-3987.
30. Munoz A., Bernal J. Biological activities of thyroid hormone receptors. Eur. J. Endocrinol. 137:(5):1997;433-445.
31. Obregon M.J., Ruiz de Ona C., Calvo R., Escobar del Rey R., Morreale de Escobar G. Outer ring iodothyronine deiodinases and thyroid hormone economy: responses to iodine deficiency in the rat fetus and neonate. Endocrinology. 129:(5):1991;2663-2673.
32. Oppenheimer J.H., Schwartz H.L. Molecular basis of thyroid hormone-dependent brain development. Endocrine Rev. 18:(4):1997;462-475.
33. Polkinghorne Report, Review of the Guidance on the Research use of Fetuses and Fetal Tissue, 1998, HMSO, London, UK.
34. Pop V.J., Kuijpens J.L., van Baar A.L. Low maternal thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin. Endocrinol. 50:1999;149-155.
35. Santini F., Pinchera A., Ceccarini G., Castagna M., Rosellini V., Mammoli C., Montanelli L., Zucchi V., Chopra I., Chiovato L. Evidence for a role of type 3 iodothyronine deiodinase in the regulation of 3,5,3′-triiodothyronine content in the human central nervous system. Eur. J. Endocrinol. 144:2001;577-583.
36. Salvatore D., Bartha T., Harney J.W., Larsen P.R. Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology. 137:(8):1996;3308-3315.
37. Silva J.E., Gordon M.B., Crantz F.R., Leonard J.L., Larsen P.R. Qualitative and quantitative differences in the pathways of extrathyroidal triiodothyronine generation between euthyroid and hypothyroid rats. J. Clin. Invest. 73:(4):1984;898-907.
38. Strait K.A., Schwartz H.L., Perez-Castillo A., Oppenheimer J.H. Relationship of c-erbA mRNA content to tissue triiodothyronine nuclear binding capacity and function in developing and adult rats. J. Biol. Chem. 265:(18):1990;10514-10521.
39. Thorpe-Beeston J.G., Nicolaides K.H., Felton C.V., Butler J., McGregor A.M. Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. New Engl. J. Med. 324:(8):1991;532-536.
40. Toyoda N., Kaptein E., Berry M.J., Harney J.W., Larsen P.R., Visser T.J. Structure-activity relationships for thyroid hormone deiodination by mammalian type I iodothyronine deiodinases. Endocrinology. 138:(1):1997;213-219.
41. Visser T.J., Kaplan M.M., Leonard J.L., Larsen P.R. Evidence for two pathways of iodothyronine 5′-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. J. Clin. Invest. 71:(4):1983;992-1002.
42. Visser T.J., Kaptein E., Terpstra O.T., Krenning E.P. Deiodination of thyroid hormone by human liver. J. Clin. Endocrinol. Metab. 67:(1):1988;17-24.